SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 2152743

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152743

Body Contouring Devices Market Size, Share & Trends Analysis Report By Type (Noninvasive and Minimally Invasive Devices, Invasive Devices), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

The global body contouring devices market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 5.7 billion in 2033, at a CAGR of 14.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% of revenue in 2025. Body contouring devices can be invasive, non-invasive, or minimally invasive and aim to reshape an area of the body. This can be done surgically via liposuction or through less invasive methods like cryolipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis. The main goal of body contouring procedures is to eliminate unwanted fat and achieve firmness in the treatment area.

The market is experiencing steady growth, driven by the rising prevalence of obesity linked to sedentary lifestyles and unhealthy dietary habits, as well as growing consumer awareness of aesthetic procedures. Continuous advancements in body contouring technologies have improved the safety, efficacy, and clinical outcomes of both surgical and non-surgical procedures, encouraging wider adoption. In addition, strategic initiatives by leading market participants, including mergers and acquisitions, new product launches, and partnerships to expand product portfolios and strengthen distribution networks, are expected to further support market growth over the forecast period.

Non-invasive fat reduction, or nonsurgical fat reduction, refers to minimally invasive treatments that break down stubborn subcutaneous fat pockets beneath the skin. Major factors driving market growth include rising demand for body-contouring treatments, as they are non-invasive and require no downtime after the procedure. SculpSure, developed by Cynosure LLC, is a non-invasive body-contouring laser device that targets and destroys around 24% of unwanted fat cells in 25 minutes.

A sedentary lifestyle is a major underlying cause of obesity, disease, and disability. Levels of physical inactivity are very high in all developed and developing countries. According to the World Obesity Federation, it is projected that over half the global population, around 4 billion people, will be living with overweight and obesity by 2035. Increased urbanization has contributed immensely to the increase in sedentary lifestyles, which in turn has escalated the prevalence of obesity globally.

Global Body Contouring Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global body contouring devices market report based on type and region:

  • Type Outlook (Revenue, USD Billion, 2021 - 2033)

Non-invasive and Minimally Invasive Devices

    • Nonsurgical Skin Resurfacing
    • Nonsurgical Skin Tightening
    • Cellulite treatment
    • Others

Invasive Devices

    • Liposuction
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • Germany
    • UK
    • France
    • Spain
    • Italy

Asia Pacific

    • China
    • Japan
    • India
    • South Korea
    • Australia

Latin America

    • Brazil
    • Argentina

Middle East and Africa

    • Saudi Arabia
    • UAE
    • South Africa
Product Code: GVR-2-68038-621-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Body Contouring Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Body Contouring Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Body Contouring Devices Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Body Contouring Devices Market: Type Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Noninvasive and Minimally Invasive Devices
    • 4.3.1. Noninvasive and Minimally Invasive Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Nonsurgical Skin Resurfacing
        • 4.3.1.1.1. Nonsurgical Skin Resurfacing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Nonsurgical Skin Tightening
        • 4.3.1.2.1. Nonsurgical Skin Tightening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Cellulite Treatment
        • 4.3.1.3.1. Cellulite Treatment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.4. Others
        • 4.3.1.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Invasive Devices
    • 4.4.1. Invasive Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Liposuction
        • 4.4.1.1.1. Liposuction Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Body Contouring Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Body Contouring Devices Market Share, By Region, 2025 & 2033 (USD Million)
  • 5.2. North America
    • 5.2.1. North America Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. U.K.
      • 5.3.2.1. U.K. Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. France Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Spain
      • 5.3.5.1. Spain Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.6. Italy
      • 5.3.6.1. Italy Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. China
      • 5.4.2.1. China Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Japan
      • 5.4.3.1. Japan Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. India Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. South Korea
      • 5.4.5.1. South Korea Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. Australia
      • 5.4.6.1. Australia Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Saudi Arabia Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. UAE
      • 5.6.3.1. UAE Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. South Africa
      • 5.6.4.1. South Africa Body Contouring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Cynosure, Inc.
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. Alma Lasers
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Allergan Plc
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Merz Pharma Gmbh
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. Candela Medical Ltd.
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. Solta Medical Bausch Health Companies, Inc.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Lutronic Corporation
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. InMode Ltd
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Fotona
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Softwave Medical LTD
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives
    • 6.4.11. Sciton Inc
      • 6.4.11.1. Participant's Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Recent Developments/ Strategic Initiatives
    • 6.4.12. Lumenis
      • 6.4.12.1. Participant's Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Recent Developments/ Strategic Initiatives
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!